Literature DB >> 25581420

Reversion of nitrate tolerance in rat aorta rings by freeze-dried red wine.

Fabio Fusi1, Giampietro Sgaragli.   

Abstract

Chronically administered organic nitrates induce nitrate tolerance and endothelial dysfunction, which limit their therapeutic use. eNOS uncoupling, ROS over-production, aldehyde dehydrogenase-2 as well as superoxide dismutase (SOD) oxidative inhibition, and cGMP desensitization are thought to play an important role. Natural polyphenols are effective antioxidants, which might counteract the mechanisms leading to nitrate tolerance. The aim of this work was to verify whether freeze-dried (dealcoholized) red wine (FDRW) was able to revert glyceryl trinitrate (GTN) tolerance and endothelial dysfunction induced in rat aorta rings with either GTN or diethyldithiocarbamate (DETCA), an irreversible inhibitor of Cu/Zn SOD. GTN induced a concentration-dependent relaxation of rings pre-contracted with phenylephrine. GTN spasmolysis was significantly reduced in rings pre-incubated with either GTN or DETCA. FDRW, at 2.8 µg of gallic acid equivalents (GAE)/mL concentration, was able to revert partially, though significantly, GTN-induced tolerance but not tolerance and endothelial dysfunction induced by DETCA. This work provides the first evidence in vitro that red wine components, at concentrations comparable to those achieved in human blood after moderate consumption of red wine, revert tolerance to nitrates with a mechanism possibly mediated by SOD.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  de-alcoholized freeze-dried red wine; glyceryl trinitrate; nitrate tolerance

Mesh:

Substances:

Year:  2015        PMID: 25581420     DOI: 10.1002/ptr.5287

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  1 in total

1.  Evaluation of possible effects of crocin against nitrate tolerance and endothelial dysfunction.

Authors:  Seyedeh Farzaneh Omidkhoda; BiBi Marjan Razavi; Mohsen Imenshahidi; Maryam Rameshrad; Hossein Hosseinzadeh
Journal:  Iran J Basic Med Sci       Date:  2020-03       Impact factor: 2.699

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.